Monday, April 24, 2017 4:18:34 PM
Wouldn't you buy the shares - I really don't see nothing more than a Tool - Granted having the rights to this or that for a illness is quite something but these's guys are about the Tool - You can find anything and in real time - be it Ebolia or Vika - Virus - Cancer - Pot - Cocaine
Chip Technologies - Program for anything via a Link - Anywhere
Going to a Product might bring further Cash needed - But I see Partnering as that cost will be contributed from Partner - The Tech or the Tool will need tweaking but don't see much cost in that - Yost Group now getting $5K from BTH and $5K from BLO - Roughly $120K a year - Trials for Illness would cost but I see us/it as Tool makers and not a passion to cure cancer or Ebolia kinda way
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM